Quality assurance committees required to be appointed by licensees
1.
Every licensee authorised to provide any of the following licensable healthcare services:
At least one Serious Reportable Event QAC
(a)
a blood banking service
(b)
a nuclear medicine service
(c)
a nursing home service
2.
Every licensee authorised to provide a nuclear medicine service, in relation to the provision of the service for a therapy purpose
At least one Mortality and Morbidity QAC
3.
Every licensee authorised to provide an acute hospital service
(i)
At least one Mortality and Morbidity QAC
(ii)
At least one Serious Reportable Event QAC
(iii)
At least one Peer Review Learning QAC
4.
Every licensee authorised to provide any of the following licensable healthcare services:
(a)
ambulatory surgical centre service
(b)
assisted reproduction service
(c)
community hospital service
(d)
outpatient renal dialysis service
(i)
At least one Mortality and Morbidity QAC
(ii)
At least one Serious Reportable Event QAC
5.
Every licensee authorised to provide an outpatient medical service and approved to provide any of the following specified services:
(a)
blood transfusion service
(b)
proton beam therapy
(c)
radiation oncology and radiation therapy
(i)
At least one Mortality and Morbidity QAC
(ii)
At least one Serious Reportable Event QAC
6.
Every licensee authorised to provide an outpatient medical service and who provides the service only to students enrolled in a primary school or secondary school
(i)
At least one Mortality and Morbidity QAC
(ii)
At least one Serious Reportable Event QAC
7.
Every licensee authorised to provide an outpatient medical service and who provides the service at a polyclinic
(i)
At least one Mortality and Morbidity QAC
(ii)
At least one Serious Reportable Event QAC
8.
Every licensee authorised to provide an outpatient medical service and who provides the service at a specialist outpatient clinic, where the licensee is a cluster HQ or its subsidiary
(i)
At least one Mortality and Morbidity QAC
(ii)
At least one Serious Reportable Event QAC
9.
Every licensee authorised to provide a contingency care service
(i)
At least one Mortality and Morbidity QAC
(ii)
At least one Serious Reportable Event QAC
[S 848/2023 wef 18/12/2023]
In Part 1 of this Schedule —
“cluster HQ” means any of the following:
(a)
National Healthcare Group Pte Ltd;
(b)
National University Health System Pte Ltd;
(c)
Singapore Health Services Pte Ltd;
“Mortality and Morbidity QAC” means a QAC established by a licensee to identify and evaluate any case for mortality and morbidity review, and take any steps that are necessary or appropriate, in accordance with the Act and these Regulations;
“Peer Review Learning QAC” means a QAC established by a licensee to review and evaluate clinical quality, safety and appropriateness of care provided by specialists employed or engaged by the licensee, and take any steps that are necessary or appropriate, in accordance with the Act and these Regulations;
“Serious Reportable Event QAC” means a QAC established by a licensee to identify and evaluate any serious reportable event that occurs in the course of providing a licensable healthcare service, and take any steps that are necessary or appropriate, in accordance with the Act and these Regulations.
Part 2
PRESCRIBED PROGRAMMES and activities in respect of which a Service Review Committee must be appointed
1. Proton beam therapy.
2. Collaborative prescribing service.
Part 3
PRESCRIBED MEDICAL TREATMENTS to be reviewed by a Clinical Ethics Committee
1. Surgical separation of conjoint twins.
2. Psychosurgery.
3. Treatment for sexual sterilisation on an unmarried person with mental capacity and below 21 years of age.
4. Reproductive organ transplant.
5. Gender reassignment surgery.
6. Deep brain stimulation for any indication other than Parkinson’s disease, dystonia, essential tremor and epilepsy.
7. Transcranial direct current stimulation.
8. Testicular biopsy, if proposed to be performed on an individual who —
(a)
has not experienced the onset of puberty and has been diagnosed with any medical condition that requires gonadotoxic therapy; or
(b)
has Klinefelter syndrome.
9. Testicular tissue freezing, if proposed to be performed on an individual who —
(a)
has not experienced the onset of puberty and has been diagnosed with any medical condition that requires gonadotoxic therapy; or
(b)
has Klinefelter syndrome.
10. The transfer of an intergenerational gamete or embryo for an assisted reproduction procedure.
11. Any treatment for a medical condition that involves the use of a cell, tissue, gene therapy product —
(a)
that is manufactured by a licensee; and
(b)
in respect of which use has not been accepted by a respectable body of medical opinion as conventional treatment for the medical condition.
12. Pre-implantation genetic diagnosis with human leukocyte antigen typing for the creation of saviour siblings.
